Rapid Detection of Shiga Toxin-Producing Escherichia coli by Optical Immunoassay
Open Access
- 1 October 2007
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 45 (10) , 3377-3380
- https://doi.org/10.1128/jcm.00837-07
Abstract
In a multi-health center study, a new rapid optical immunoassay (OIA) for the detection of Shiga toxin types 1 and 2, the BioStar OIA SHIGATOX kit (Inverness Medical Professional Diagnostics, Inc.), was used to prospectively screen 742 fresh fecal samples for Shiga toxins in parallel with the Premier enterohemorrhagic Escherichia coli (EHEC) kit (Meridian BioScience, Inc.) with and without enrichment of the specimens by incubation in MacConkey broth. Additionally, 85 previously tested frozen fecal samples were assessed as described above. All positive immunoassay results were confirmed by the Vero cell cytotoxicity assay. A further modification of the screening procedure was evaluated on 470 of the prospectively screened specimens. Swabs of growth from conventionally plated stool culture media were subjected to the OIA SHIGATOX, and results were compared with those obtained with the Premier EHEC kit following broth enrichment. Overall, the OIA SHIGATOX kit was significantly more sensitive than the Premier EHEC kit on fresh direct stool specimens (sensitivities, 96.8% and 83.9%, respectively; P < 0.05). The two assays performed equally well with each other on frozen and broth-enriched samples. The colony sweep method used in conjunction with the OIA kit was somewhat more effective at detection of Shiga toxins from growth on agar than the overnight broth enrichment procedure used with the Premier EHEC assay (sensitivities, 100% and 92%, respectively; P < 0.09). Overall, the OIA SHIGATOX kit provided rapid, easy-to-interpret results and was highly effective at detection of Shiga toxin-producing E. coli in fecal samples and overnight cultures.Keywords
This publication has 14 references indexed in Scilit:
- The Emerging Clinical Importance of Non-O157 Shiga Toxin--Producing Escherichia coliClinical Infectious Diseases, 2006
- Human Antibody against Shiga Toxin 2 Administered to Piglets after the Onset of Diarrhea Due to Escherichia coli O157:H7 Prevents Fatal Systemic ComplicationsInfection and Immunity, 2005
- Phase 1 Safety and Pharmacokinetic Study of Chimeric Murine-Human Monoclonal Antibody cαStx2 Administered Intravenously to Healthy Adult VolunteersAntimicrobial Agents and Chemotherapy, 2005
- Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndromeThe Lancet, 2005
- Laboratory Practices for Stool‐Specimen Culture for Bacterial Pathogens, IncludingEscherichia coliO157:H7, in the FoodNet Sites, 1995–2000Clinical Infectious Diseases, 2004
- Outbreak of Shiga Toxin–ProducingEscherichia coliO111:H8 Infections among Attendees of a High School Cheerleading CampClinical Infectious Diseases, 2004
- Shiga Toxin-Producing Escherichia coli -Associated Kidney Failure in a 40-Year-Old Patient and Late Diagnosis by Novel Bacteriologic and Toxin Detection MethodsJournal of Clinical Microbiology, 2003
- Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapyPediatric Nephrology, 2002
- Food-Related Illness and Death in the United StatesEmerging Infectious Diseases, 1999
- Isolation of Shiga-like toxin producing Escherichia coli (O157 and non-O157) in a community hospitalDiagnostic Microbiology and Infectious Disease, 1996